We are live on ! Find out more
SI

Scharf Investments Portfolio holdings

AUM $3.03B
1-Year Est. Return 7.75%
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$2.57B
AUM Growth
+$325M
Cap. Flow
+$145M
Cap. Flow %
5.64%
Top 10 Hldgs %
48.66%
Holding
41
New
5
Increased
24
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$63.6M
2
ORCL icon
Oracle
ORCL
+$11M
3
CHL
China Mobile Limited
CHL
+$10.7M
4
DOC icon
Healthpeak Properties
DOC
+$7.85M
5
VYX icon
NCR Voyix
VYX
+$7.79M

Sector Composition

Rank Sector Weight
1 Healthcare 24.6%
2 Technology 23.23%
3 Energy 16.02%
4 Financials 12.76%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
DELISTED
Allergan Inc
AGN
$141M 5.48%
832,988
+8,962
+1% +$1.4M
AAPL icon
2
Apple
AAPL
$4.54T
$135M 5.26%
5,830,804
+198,184
+4% +$4.22M
HAL icon
3
Halliburton
HAL
$26.9B
$135M 5.22%
1,894,159
-150,107
-7% -$9.62M
MSFT icon
4
Microsoft
MSFT
$3.45T
$129M 5%
3,084,806
+132,584
+4% +$5.37M
APA icon
5
APA Corp
APA
$13.2B
$126M 4.9%
1,252,884
+55,611
+5% +$5.04M
AAP icon
6
Advance Auto Parts
AAP
$3.35B
$120M 4.65%
886,856
+60,145
+7% +$7.45M
CVS icon
7
CVS Health
CVS
$133B
$118M 4.58%
1,564,780
+71,949
+5% +$5.44M
CHL
8
DELISTED
China Mobile Limited
CHL
$118M 4.57%
2,420,578
+223,138
+10% +$10.7M
VYX icon
9
NCR Voyix
VYX
$1.14B
$117M 4.53%
5,414,565
+385,464
+8% +$7.79M
NVS icon
10
Novartis
NVS
$297B
$115M 4.47%
1,419,883
+25,852
+2% +$2.03M
BAX icon
11
Baxter International
BAX
$13.5B
$113M 4.37%
2,865,088
+166,904
+6% +$6.68M
ORCL icon
12
Oracle
ORCL
$374B
$112M 4.36%
2,770,507
+268,528
+11% +$11M
AIG icon
13
American International
AIG
$41.7B
$108M 4.2%
1,980,241
+112,456
+6% +$5.95M
IBM icon
14
IBM
IBM
$211B
$104M 4.05%
602,215
+34,363
+6% +$6.18M
SNY icon
15
Sanofi
SNY
$103B
$102M 3.95%
1,913,989
+42,346
+2% +$2.25M
DG icon
16
Dollar General
DG
$28B
$100M 3.9%
1,751,754
+116,216
+7% +$6.64M
AFL icon
17
Aflac
AFL
$64.9B
$100M 3.89%
3,218,350
+226,810
+8% +$7.08M
CVX icon
18
Chevron
CVX
$392B
$84.6M 3.29%
648,299
+13,719
+2% +$1.71M
TTE icon
19
TotalEnergies
TTE
$195B
$65.3M 2.54%
904,537
+29,487
+3% +$2.06M
MKL icon
20
Markel Group
MKL
$23.3B
$64.3M 2.5%
98,066
+4,096
+4% +$2.58M
BIDU icon
21
Baidu
BIDU
$37.7B
$64M 2.48%
342,356
+17,080
+5% +$2.8M
TGT icon
22
Target
TGT
$65.6B
$62.7M 2.43%
+1,081,371
New +$63.6M
CP icon
23
Canadian Pacific Kansas City
CP
$78.1B
$61.5M 2.39%
1,698,945
-182,225
-10% -$5.97M
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.1T
$55.9M 2.17%
441,404
+42,770
+11% +$5.41M
HMC icon
25
Honda
HMC
$39.1B
$44.4M 1.73%
1,269,807
+85,591
+7% +$2.93M

Similar funds

Scharf Investments's Q2 2014 Portfolio in Review

As of Q2 2014, Scharf Investments held 41 positions worth $2.57B, up 14% from $2.25B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Scharf Investments deployed $145M of net new capital in Q2 2014, opening 5 new positions and adding to 24 existing holdings. Its largest new stake was Target: 1,081,371 shares worth $62.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Murphy USA, an estimated $25.8M trimmed.

  • Scharf Investments's largest Q2 2014 buy was Target: 1,081,371 shares worth $62.7M.
  • Scharf Investments added most to Oracle in Q2 2014, an estimated $11M increase.
  • Scharf Investments's biggest Q2 2014 reduction was Murphy USA, cutting an estimated $25.8M.
  • Scharf Investments's ten largest holdings make up 49% of its $2.57B portfolio in Q2 2014.
  • Scharf Investments opened 5 new positions and closed 1 in Q2 2014.
  • Scharf Investments's portfolio value rose 14% quarter-over-quarter to $2.57B.

Based on Scharf Investments's 13F filing for Q2 2014, filed 13 Aug 2014.